Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Glenmark
Pharma
Carvykti, AstraZeneca, Samsung—Fierce Pharma Asia
Carvykti's earlier multiple myeloma bid will face an adcomm. AZ's oral factor D drug won its world-first approval. Samsung's CDMO unit records growth.
Angus Liu
Jan 26, 2024 11:08am
WuXi, Daiichi-Novartis, Merck KGaA-Abbisko—Fierce Pharma Asia
Dec 8, 2023 8:13am
AZ-Daiichi, Padcev, AbbVie—Fierce Pharma Asia
Sep 29, 2023 10:45am
Glenmark addresses debt with $681M sale of API unit to Nirma
Sep 22, 2023 11:00am
Vyvanse, Keytruda-Lenvima, Adagene-ADC—Fierce Pharma Asia
Sep 1, 2023 8:50am
Moderna, GSK and Glenmark—Fierce Pharma Asia
Aug 25, 2023 9:20am